Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Regulatory News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.00
Bid: 97.00
Ask: 98.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.031%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 98.00
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Annual Report and Notice of AGM

23 Apr 2020 07:00

RNS Number : 5589K
Diaceutics PLC
23 April 2020
 

Diaceutics PLC

("Diaceutics" or the "Company")

 

Posting of Annual Report and Notice of AGM

 

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces that it will today post its Annual Report for the year ended 31 December 2019 to shareholders together with the Notice of the 2020 Annual General Meeting ("AGM") and Form of Proxy. Also included with this communication is a deemed consent letter to allow shareholders to register their preference on how they wish to receive shareholder documentation in the future.

 

The Company will hold its AGM on Tuesday 19 May 2020. Following the UK Government's announcement on 23 March 2020 imposing mandatory social distancing measures, including restrictions on gathering of more than two people, the Company's 2020 AGM will be convened with the minimum quorum of shareholders present in order to conduct the business of the meeting. Shareholders are encouraged to appoint the Chairman of the meeting as their proxy and submit their voting instructions in advance by completing and signing the Form of Proxy accompanying the Notice of the 2020 AGM (or appoint a proxy electronically if their shares are held in CREST) before 2pm on Friday 15 May 2020. Shareholders must not attend the AGM in person.

 

The Annual Report and Notice of AGM will also be available on the Company's website shortly at www.diaceutics.com.

 

Enquiries:

 

Diaceutics PLC

www.diaceutics.com

Peter Keeling, Chief Executive Officer

via Walbrook PR

Philip White, Chief Financial Officer

 

 

 

Cenkos Securities plc (Nominated adviser and broker)

+44 (0)207 397 8900

Callum Davidson / Giles Balleny

 

Michael Johnson (Sales)

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or diaceutics@walbrookpr.com

Anna Dunphy

Mob: +44 (0)7876 741 001

Paul McManus

Mob: +44 (0)7980 541 893

 

About Diaceutics

Diaceutics PLC is the diagnostic commercialisation company for global pharmaceutical companies. The Company, quoted on the Alternative Investment Market (AIM) of the London Stock Exchange, is enabling pharma to accelerate their market penetration and achieve a better return on precision medicine therapies by helping them to revolutionise patient testing. By generating insights from its data lake of clinical laboratory testing data and other data, Diaceutics helps pharma understand and leverage the diagnostic landscape through initiatives that improve patient testing, leading to better treatment outcomes. The Company works with more than 35 global pharmaceutical companies across hundreds of precision medicine projects. The Company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries. www.diaceutics.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOABUGDSLUDDGGD
Date   Source Headline
7th Sep 202011:00 amRNSPrice Monitoring Extension
7th Sep 20207:00 amRNSHalf-year Report
27th Aug 20207:00 amRNSNotice of Results
22nd Jul 20207:00 amRNSNew contract win for DXRX platform
9th Jul 20207:00 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading update
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
3rd Jul 202010:43 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSIssue of Share Options
29th Jun 20202:55 pmRNSResult of General Meeting
19th Jun 20207:00 amRNSHolding(s) in Company
11th Jun 20202:00 pmRNSExercise of warrant
11th Jun 20207:00 amRNSPlacing of £20.5 million
19th May 20202:29 pmRNSResult of AGM
19th May 20207:00 amRNSAGM Statement
18th May 20207:00 amRNSDiagnostic network for precision medicine update
5th May 202011:22 amRNSDirector’s Shareholding - PCA Dealing
29th Apr 20207:00 amRNSCancer testing & diagnosis suffers sharp downturn
23rd Apr 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Apr 20207:00 amRNSIssue of Share Options
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20209:05 amRNSSecond Price Monitoring Extn
17th Mar 20209:00 amRNSPrice Monitoring Extension
16th Mar 202011:05 amRNSSecond Price Monitoring Extn
16th Mar 202011:00 amRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSFinal Results
12th Mar 20202:24 pmRNSPrivate investor briefing
27th Feb 20207:00 amRNSNotice of Results
17th Feb 20207:00 amRNSBelfast investor presentation
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
17th Jan 20202:53 pmRNSHolding(s) in Company
13th Jan 20209:05 amRNSSecond Price Monitoring Extn
13th Jan 20209:00 amRNSPrice Monitoring Extension
13th Jan 20207:00 amRNSYear-End Trading Update
25th Nov 20197:00 amRNSPresentation at AICon 2019
24th Oct 20197:00 amRNSPresentation at Big Data Belfast
21st Oct 20197:00 amRNSPharma Precision Medicine Readiness Report
10th Oct 20197:00 amRNSWorkshop presentation at EORTC
30th Sep 20198:01 amRNSPoster presentation at ESMO
23rd Sep 20197:00 amRNSDublin investor presentation
9th Sep 20197:00 amRNSHalf-year Report
8th Aug 20197:00 amRNSAppointment of Head of Global Data
8th Aug 20197:00 amRNSNotice of Results
8th Jul 20197:00 amRNSTrading update
17th Jun 20197:00 amRNSInvestment in data lake
28th May 20197:00 amRNSInvestor presentation
25th Mar 20194:29 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSHolding(s) in Company
21st Mar 20192:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.